GlassScriptPhysician profile
Janell Langley
NPI 1689377145
$805.08
in general payments reported to CMS, 2019-2025
14 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $301 · 2024: $312 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $193.80 | 2023-2025 | |
| Astellas Pharma US INC | $97.71 | 2023-2024 | Veozah |
| Merck Sharp & Dohme LLC | $86.19 | 2024-2025 | Gardasil 9, Capvaxive, Vaxelis |
| Pfizer INC. | $75.57 | 2023 | |
| Lilly USA, LLC | $70.66 | 2024-2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $68.09 | 2023-2024 | |
| Novo Nordisk INC | $61.00 | 2023-2024 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $38.13 | 2024 | Airsupra |
| Organon LLC | $24.25 | 2023 | Nexplanon |
| Amgen INC. | $22.66 | 2024 | Evenity, Prolia |
| Janssen Pharmaceuticals, INC | $17.84 | 2023 | Spravato |
| Sanofi Pasteur INC. | $17.30 | 2023 | |
| Exact Sciences Corporation | $16.21 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $15.67 | 2024 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janell Langley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.